~~<i id='AF4A4D71B5'><strike id='AF4A4D71B5'><tt id='AF4A4D71B5'><pre id='AF4A4D71B5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：Wikipedia 2025-09-30 18:21:19 - browse：2664

Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： A $475,000 price tag for a new cancer drug: crazy or meh?

leisure time

Wikipedia

focus

Wikipedia

hotspot

AdobeI’vespentagooddealofmycareerthinkingabouthowwestructureandfundresearchinthebiomedicalsciencesin

WSS

Vertex non

Hilary may become 1st tropical storm to make landfall in California in 84 years

Evacuations in place as 3 wildfires burn in eastern Washington state

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Juul spent big to court Black leaders to promote its e

FDA drug safety: Singulair case shows systemic surveillance flaws

focus

comprehensive

leisure time

Continuity nursing helped my family in our darkest PICU moments

ARCH Venture Partners is raising $3 billion for a life sciences fund

Affirmative action in medical school literally saved lives

Congressmen charge Covid hearing ‘could have been an email’

In Memoriam: Notable people who died in 2023

Juul spent big to court Black leaders to promote its e

Bright Health sells Medicare Advantage business to Molina

Hilary expected to bring catastrophic, life

Drug repurposing or repositioning? The language matters

ProMED sees offers of support, but its future remains unclear

Wikipedia

ARCH Venture Partners is raising $3 billion for a life sciences fund

Congressmen charge Covid hearing ‘could have been an email’

Hilary expected to bring catastrophic, life

Eye stem cell transplant could help restore vision in injured people

Lung cancer is America's deadliest cancer. Yet so few get screened

Clinical trials must include more disabled people

focus

Wikipedia

hotspot

hotspot